Abstract
Introduction: The gut-brain hypothesis proposes that Parkinson's disease (PD) pathology may start in the gut and later spread to the brain in a prion-like manner. As PD pathology is redundant in the appendix and tonsils, which are important gut-associated lymphoid tissues, we examined whether appendectomy and tonsillectomy were associated with later PD risk.
Methods: The nested case-control study included 78,650 PD patients born in 1900–1980 and with a diagnosis of PD between 1964 and 2010. For each PD patient, we randomly selected 40 non-PD controls individually matched for sex and year of birth at the date of PD diagnosis. Appendectomy and tonsillectomy before PD diagnosis were ascertained from the Swedish Patient Register from 1964 onward. We calculated odds ratios (OR) with 95% confidence intervals (CI) using conditional logistic regression adjusting for country of birth, highest achieved education, COPD, comorbidity index, and number of hospital visits.
Results: Overall, we found 16% lower risk of PD linked to previous appendectomy (OR = 0.84, 95% CI: 0.80–0.88) and 8% lower risk of PD linked to previous tonsillectomy, although not statistically significant (OR = 0.92, 95% CI: 0.81–1.04). A 7 and 15% lower risk of PD was also noted ≥20 years after appendectomy and tonsillectomy, respectively. Similar associations were observed for men and women but were stronger for PD diagnosed after age 60.
Conclusion: Appendectomy and potentially also tonsillectomy were associated with a lower risk PD. A potential mechanism may involve surgical removal of alpha-synuclein redundancy in the appendix and tonsils.
Keywords: Parkinson's disease, appendectomy, tonsillectomy, nested case-control, register-based
Introduction
The so-called dual-hit hypothesis about the pathogenesis of idiopathic Parkinson's disease (PD) states that neutrophic pathogens may enter the brain through two portals— the nasal cavity and the gut (1–3). Deposition of alpha-synuclein has been found throughout the entire gut with most dense expression in the appendix of both PD patients and healthy individuals (4). Although still controversial, there is evidence that alpha-synuclein pathology may be transported from cell to cell and thereby spread from the nasal cavity or gut to the brain (2, 3). Mounting evidence has also linked neuroinflammation with PD development (5).
The tonsils and the appendix are important gut-associated lymphoid tissues in the mucosa-associated immune system (6). Surgical procedures to remove these organs often occur in early childhood or adolescence due to recurrent or acute infections, which may cause long-term alteration in immune function. Previous studies have linked these procedures to risk of multiple sclerosis (7) and inflammatory bowel diseases (8). Given the potential spread of alpha-synuclein from the nasal cavity and gut to the brain and the involvement of the tonsils and appendix in immune function, one might hypothesize that surgical removal of these organs may lower the risk of PD. However, previous results are inconclusive, two studies reported that appendectomy was linked to lower risk of PD or delayed PD onset (9, 10), whereas four other studies suggested either a slightly increased PD risk after appendectomy or no association (11–14). Evidence for tonsillectomy and PD risk is scarce; one study reported no association between tonsillectomy and PD risk (15).
We aimed to evaluate the association of appendectomy and tonsillectomy with PD risk in Swedish nationwide registers. In addition to examining appendectomy and tonsillectomy as binary exposures, we also explored the potential temporal relationship between these surgeries and PD risk and the impact of sex and age on the associations.
Materials and Methods
Swedish Health and Population Registers
The Swedish Patient Register was established in 1964–1965 and collects information on dates of admission and discharge of hospitalizations, surgical procedures, and medical diagnoses (16, 17). Coverage of this register became complete in 1987 and was expanded to cover surgical day-care procedures in 1997 and outpatient visits in 2001 (18). The Causes of Death Register records nationwide information on deaths since 1952, and the Total Population Register contains information on dates of immigration and emigration (19). The Swedish Population and Housing Censuses were conducted every 5 years from 1960 to 1990 to collect detailed information on housing, civil status, and socioeconomic status (20).
Ascertainment of PD
PD cases were identified from the Patient Register using Swedish revisions of International Classification of Diseases (ICD) codes (i.e., ICD-7: 350 in 1964–1968; ICD-8: 342 in 1969–1986; ICD-9: 332.0 in 1987–1996; and ICD-10: G20 from 1997 onward). Both primary and secondary PD diagnoses were considered. PD is assigned as the primary diagnosis in the Patient Register when PD is considered the main reason for hospitalization, whereas it is assigned as a secondary diagnosis when another condition is considered the main reason. In a previous validation study, compared to clinical workup, positive predicted value (PPV) for inpatient PD diagnosis was 70.8% for primary or secondary PD diagnosis and increased to 80.3% when restricted to primary diagnosis (21).
Ascertainment of Appendectomy and Tonsillectomy
Information on appendectomy was obtained from the Patient Register according to the Swedish Classification of Operations and Major Procedures codes (4510, 4511, 4517, 0058 in 1964-1996, and JEA00, JEA01, JEA10 from 1997 onward). Information on tonsillectomy was obtained using the codes 2710 and 2720 in 1964-1996, and EMB10, EMB20, EMB30, EMB99 from 1997 onward.
Study Design
We conducted a nested case-control study based on individuals who were born between 1900 and 1980 and who participated in the Swedish Population and Housing Census in 1970 or 1980. PD cases were identified from the Patient Register between January 1, 1964 and December 31, 2010. For each PD case, we randomly selected 40 controls who were alive and living in Sweden without previous PD diagnosis, individually matched to the PD patient on sex and year of birth on the date of PD diagnosis. Date of PD diagnosis is hereafter referred to as index date. The final study population encompassed 78,650 PD cases and 3,146,000 non-PD controls.
Co-variates
We retrieved information on country of birth (Swedish vs. non-Swedish born) from the Total Population Register and data on educational attainment (≤9, 10–12, ≥13 years, or unknown) from the Swedish Register of Education. Smoking has consistently been linked to lower risk of PD (22) and also to higher risk of appendectomy (23) and tonsillitis, which is the main indication for tonsillectomy (24). As self-reported information on smoking was not available, we used lifetime chronic obstructive pulmonary disease (COPD) as a proxy for smoking similar to a previous study (25). We obtained information on comorbidity from the Patient Register between 1964 and index date, and further weighted and categorized this information according to Deyo's modification of the Charlson's Comorbidity Index (0, 1–2, or ≥3 points) (26) ICD codes were presented in our previous study (25). As a measurement of surveillance bias related to comorbidity, including appendicitis or tonsillitis, such that these individuals may have more frequent hospital visits and therefore greater likelihood of receiving PD diagnosis compared to others, we obtained information on number of hospital visits before index date from the Patient Register (both inpatient and outpatient), categorized according to tertiles (0–1, 2, or ≥3 visits). Age at index date was categorized as <60, 60–69, 70–79, or >80 years.
Statistical Analysis
The associations between appendectomy, tonsillectomy, and PD risk were expressed as odds ratios (ORs) with 95% confidence intervals (CIs) estimated from conditional logistic regression. We first analyzed the combined effect of appendectomy and tonsillectomy in relation to PD risk. Individuals who underwent either appendectomy or tonsillectomy or both were defined as exposed and were compared with individuals who had neither surgery regarding PD risk. Second, we performed separate regression analyses for appendectomy and tonsillectomy in relation to PD risk. We performed the above described analyses in two adjustment steps: first, conditional on sex and birth year matched sets; second, additionally adjusted for country of birth, educational attainment, COPD, comorbidity index, and number of hospital visits. We performed temporal relationship analyses exploring PD risk ≥5, ≥10, and ≥20 years after surgeries. We conducted sub-analyses including interaction terms between surgery and sex, as well as surgery and age at index date (<60, 60–69, 70–79, or ≥80). In addition, we performed a sensitivity analysis restricted to PD cases identified through primary diagnosis. We used Stata 15 and SAS 9.4 for statistical analyses with 2-sided alpha of 0.05.
Results
The distributions of sex and year of birth were balanced between PD cases and controls due to matching (Table 1). The mean age (±SD) at PD diagnosis was 74.0 ± 9.19 years. Individuals who were born outside of Sweden, had ≤ 9 or 10–12 years of education, or had COPD showed lower PD risk. Individuals with unknown educational attainment, more comorbidities, or more frequent hospital visits had a higher risk of PD.
Table 1.
PD cases, N (%) | Controls, N (%) | OR (95% CI)a | P-valueb | |
---|---|---|---|---|
Total | 78,650 (100) | 3,146,000 (100) | ||
Sex | ||||
Male | 43,533 (55.4) | 1,741,320 (55.4) | ||
Female | 35,117 (44.6) | 1,404,680 (44.6) | ||
Age at index date, years | ||||
<60 | 5,827 (7.4) | 234,176 (7.4) | ||
60–69 | 16,041 (20.4) | 641,304 (20.4) | ||
70–79 | 36,039 (45.8) | 1,440,524 (45.8) | ||
≥80 | 20,743 (26.4) | 829,996 (26.4) | ||
Born in Sweden | <0.01 | |||
Unknown | 2 (0) | 815 (0) | ||
No | 4,464 (5.7) | 186,688 (5.9) | 0.95 (0.92–0.98) | |
Yes | 74,184 (94.3) | 2,958,497 (94) | 1 | |
Highest achieved education, years | <0.0001 | |||
Unknown | 25,126 (31.9) | 955,824 (30.4) | 1.81 (1.72–1.90) | |
≤ 9 | 30,247 (38.5) | 1,273,971 (40.5) | 0.89 (0.86–0.91) | |
10–12 | 15,861 (20.2) | 640,729 (20.4) | 0.92 (0.89–0.95) | |
>12 | 7,416 (9.4) | 275,476 (8.8) | 1 | |
Chronic obstructive pulmonary disease (COPD) | <0.0001 | |||
No | 74,818 (95.1) | 2,930,034 (93.1) | 1 | |
Yes | 3,832 (4.9) | 215,966 (6.9) | 0.69 (0.67–0.72) | |
Comorbidity index | <0.0001 | |||
0 | 50,235 (63.9) | 2,167,220 (68.9) | 1 | |
1–2 | 21,768 (27.7) | 749,584 (23.8) | 1.29 (1.27–1.31) | |
≥3 | 6,647 (8.5) | 229,196 (7.3) | 1.31 (1.27–1.34) | |
Number of hospital visits | <0.0001 | |||
0–1 | 24,021 (30.5) | 1,310,741 (41.7) | 1 | |
2 | 20,913 (26.6) | 755,964 (24.0) | 1.72 (1.69–1.76) | |
≥3 | 33,716 (42.9) | 1,079,295 (34.3) | 2.19 (2.15–2.24) |
Logistic regression conditional on birth year and sex;
Wald-test p-value for categorical variables.
Appendectomy and PD Risk
We identified a total of 80,028 individuals who had an appendectomy. We observed a marginally significant 2% decreased PD risk after an appendectomy after adjusting for sex and birth year matching pairs (Table 2, model 1), and 16% decreased PD risk (HR = 0.84, 95% CI = 0.80–0.88) when additionally adjusted for country of birth, highest achieved education, COPD, comorbidity index, and number of hospital visits (Table 2, model 2). In the temporal relationship analyses, we noted 31, 24, and 22% lower risk of PD with in 5, 10, and 20 years after the surgery, respectively. The inverse associations remained statistically significant with 13, 12, and 7% decreased PD risk observed more than 5, 10, or 20 years post the surgery (Table 2, model 2). We found similar results for men and women and slightly stronger associations for PD diagnosed after age 60 (Table 2, model 2). Similar results were observed when restricted to PD defined through primary diagnosis (Table S1).
Table 2.
N | PD cases | Controls | Model 1aa | Model 2b |
---|---|---|---|---|
N | OR (95% CI) | OR (95% CI)b | ||
Appendectomy | ||||
No | 76,742 (97.6) | 3,067,880 (97.5) | 1 | 1 |
Yes | 1,908 (2.4) | 78,120 (2.5) | 0.98 (0.93–1.02) | 0.84 (0.80–0.88) |
Years before index date | ||||
<5 | 232 (0.3) | 11,104 (0.4) | 0.84 (0.73–0.95) | 0.69 (0.60–0.79) |
≥5 | 1,676 (2.1) | 67,016 (2.1) | 1.00 (0.95–1.05) | 0.87 (0.83–0.92) |
<10 | 511 (0.6) | 22,371 (0.7) | 0.91 (0.84–1.00) | 0.76 (0.69–0.83) |
≥10 | 1,397 (1.8) | 55,749 (1.8) | 1.00 (0.95–1.06) | 0.88 (0.83–0.93) |
<20 | 1,025 (1.3) | 44,027 (1.4) | 0.93 (0.87–0.99) | 0.78 (0.73–0.83) |
≥20 | 883 (1.1) | 34,093 (1.1) | 1.04 (0.97–1.11) | 0.93 (0.87–0.99) |
Stratified by Sex | ||||
Male | 874 (1.1) | 36,133 (1.1) | 0.97 (0.90–1.03) | 0.84 (0.78–0.90) |
Female | 1,034 (1.3) | 41,987 (1.3) | 0.98 (0.92–1.05) | 0.85 (0.80–0.90) |
Stratified by age at index date, years | ||||
<60 | 253 (0.3) | 9,538 (0.3) | 1.06 (0.94–1.21) | 0.90 (0.79–1.02) |
60–69 | 444 (0.6) | 17,756 (0.6) | 1.00 (0.91–1.10) | 0.85 (0.77–0.93) |
70–79 | 776 (1.0) | 32,535 (1.0) | 0.95 (0.89–1.02) | 0.82 (0.76–0.88) |
≥80 | 435 (0.6) | 18,291 (0.6) | 0.95 (0.86–1.05) | 0.86 (0.78–0.94) |
Logistic regression conditional on birth year and sex;
Logistic regression conditional on birth year and sex, and additionally adjusted for country of birth, highest achieved education, COPD, comorbidity index, and number of hospital visits.
Tonsillectomy and PD Risk
We identified 9,341 individuals who underwent tonsillectomy. There was a trend that previous tonsillectomy was associated with a lower risk of PD in the fully adjusted model (Table 3, model 2), with a more prominent a risk reduction for tonsillectomy performed more than 20 years before PD diagnosis, but the associations were not statistically significant (Table 3, model 2). Similar results were observed when restricted to PD defined through primary diagnosis (Table S2).
Table 3.
N | PD cases | Controls | Model 1aa | Model 2b |
---|---|---|---|---|
N | OR (95% CI) | OR (95% CI)b | ||
Tonsillectomy | ||||
No | 78,409 (99.7) | 3,136,900 (99.7) | 1 | 1 |
Yes | 241 (0.3) | 9,100 (0.3) | 1.06 (0.93–1.21) | 0.92 (0.81–1.04) |
Years before index date | ||||
<5 | 26 (0) | 954 (0) | 1.09 (0.74–1.61) | 0.91 (0.62–1.34) |
≥5 | 215 (0.3) | 8,146 (0.3) | 1.06 (0.92–1.21) | 0.92 (0.80–1.05) |
<10 | 59 (0.1) | 2,014 (0.1) | 1.17 (0.90–1.52) | 0.98 (0.75–1.27) |
≥10 | 182 (0.2) | 7,086 (0.2) | 1.03 (0.89–1.19) | 0.90 (0.77–1.04) |
<20 | 136 (0.2) | 4,699 (0.1) | 1.16 (0.98–1.37) | 0.98 (0.83–1.16) |
≥20 | 105 (0.1) | 4,401 (0.1) | 0.95 (0.79–1.16) | 0.85 (0.70–1.03) |
Stratified by Sex | ||||
Male | 141 (0.2) | 5,247 (0.2) | 1.08 (0.91–1.27) | 0.92 (0.78–1.09) |
Female | 100 (0.1) | 3,853 (0.1) | 1.04 (0.85–1.27) | 0.91 (0.75–1.11) |
Stratified by age at index date, years | ||||
<60 | 93 (0.1) | 3,081 (0.1) | 1.21 (0.98–1.50) | 1.02 (0.83–1.26) |
60–69 | 63 (0.1) | 2,600 (0.1) | 0.97 (0.75–1.25) | 0.83 (0.64–1.07) |
70–79 | 62 (0.1) | 2,489 (0.1) | 1.00 (0.77–1.28) | 0.88 (0.68–1.13) |
≥80 | 23 (0) | 930 (0) | 0.99 (0.65–1.50) | 0.90 (0.60–1.36) |
Logistic regression conditional on birth year and sex;
Logistic regression conditional on birth year and sex, and additionally adjusted for country of birth, highest achieved education, COPD, comorbidity index, and number of hospital visits.
Discussion
In this nationwide nested case-control study, we found a lower PD risk in relation to appendectomy and a non-significant trend toward lower PD risk in relation to tonsillectomy. The inverse associations were generally stronger within 20 years after surgery but remained statistically significant more than 20 years post-surgery. The associations were similar in men and women, but stronger after age 60 compared to before.
According to Braak's hypothesis, alpha-synuclein, the hallmark for PD pathology, may originate in the gut and later migrate to the brain via the vagus nerve (1). In line with this, deposits of alpha-synuclein have been observed in the entire gastrointestinal tract more than 20 years before PD onset (27). Notably, however, out of the entire gastrointestinal system, mucosal alpha-synuclein was most abundant in the appendix in individuals without neurological disease (28). Alpha-synuclein aggregates were equally abundant in normal and inflamed appendiceal tissue (10). More intriguingly, we and others reported lower PD risk more than 20 years after vagotomy (i.e., a surgical procedure resecting the vagus nerve) (25, 29). This evidence collectively suggests that the appendix may act as a reservoir for alpha-synuclein, and, in line with our results, removing the appendix may be linked to lower risk for PD.
Braak's hypothesis was further extended to the dual-hit hypothesis stating that environmental neurotrophic pathogens may spread to the brain from the nasal gateway as well as from the gut (2, 3). Moreover, there is an increasing recognition of PD as a “prion-like” disease supported by the observations of cell-to-cell α-synuclein transmission in grafted neurons in PD patients (30, 31) and the spread of intragastrical injected α-synuclein from the enteric nerve system to the brain in mice (32). The tonsils and the appendix are important gut-associated lymphoid tissues that together with mesenteric lymph nodes, protect hosts against gastro-intestinal infections (6). In transmissible prion-disease, such as Creutzfeld Jakob disease, prions first accumulate within gut-associated lymphoid tissues such as tonsils and the appendix, and later spread to the brain via the enteric nervous system (6). A similar pattern may be hypothesized for the spreading of alpha-synuclein in PD.
One potential explanation for our observed decreased PD risk related to appendectomy is bias. Residual confounding is one potential bias that needs to be considered. Cigarette smoking has been consistently linked to lower risk of PD (22), and although evidence is scarce, it has also been associated with higher risk of appendicitis (23) and chronic or recurrent tonsillitis (24). As this was a register-based study, we unfortunately lacked information on cigarette smoking, but we adjusted for COPD as a proxy for smoking. Another potential bias is reverse causation, which can be present if PD patients would be less likely to be diagnosed with or undergo appendectomy compared to the general population, for example due to very advanced PD. Further, PD has a long prodromal phase (33) and there is a delay between onset of PD symptoms to first inpatient register diagnosis of about 7 years (21). Taking advantage of the long follow-up time in our study, we performed temporal analyses that addressed this issue. Even though we found a stronger inverse association during the period shortly before appendectomy compared to the period longer before, we still observed a statistically significant inverse association more than 20 years before appendectomy. If the hypothesis that appendectomy or tonsillectomy protects against PD is true, a dose-response effect might be expected, such that the inverse association would be stronger with longer duration between surgery and PD. We may speculate that one reason that we did not observe such pattern is reverse causation, but we find it unlikely that our results are explained entirely by reverse causation. Another potential bias is incomplete coverage of the Patient Register before it became nationwide. Individuals who lived in counties covered by the register may be more likely to have both surgery and PD diagnoses captured and vice versa, but this would introduce an underestimation of an inverse association, meaning that the true association would be even stronger than the one observed.
Our results are in line with the previous studies that reported lower PD risk after appendectomy (9, 10). The Killinger et al. study (10) was also based on Swedish register data, but we used a different study design and different definitions of appendectomy and PD, resulting in that our study identified more than 3 times as many PD cases with appendectomy. We also adjusted for several co-variates, including COPD as a proxy for smoking, which they did not. Three previous studies reported that appendectomy was not related to PD risk (11, 13, 14) and one reported higher PD risk after appendectomy (12). Potential explanations include differential definitions of PD cases and controls, surveillance bias, which may result in an artificial positive association between PD and surgery, and inadequate length of follow-up precluding exploration of a potential long-term protective effect of appendectomy on PD. Our results for tonsillectomy were consistent with the Danish study that reported 5% non-significant lower risk of PD after tonsillectomy.
The main strengths of this study are the large population-based sample of more than 3.2 million individuals and the long study period between 1964 and 2010, which allowed us to examine the time-dependent relationship between appendectomy, tonsillectomy, and risk of PD. We used a rigorous matching design and adjusted for several covariates to reduce confounding. We performed sensitivity analysis restricted to primary PD diagnosis to test the robustness of the results. The study also has some limitations. First, PD register diagnoses are not perfect and there is a delay between onset of motor symptoms and first inpatient register PD diagnosis (21). However, the potential misclassification of PD is likely to be non-differential with regard to appendectomy or tonsillectomy, which would result in diluted estimates of the associations. Second, due to lack of information in the registers we were not able to control for potential confounding by lifestyle factors and medication use.
In conclusion, our data suggest that appendectomy and potentially also tonsillectomy are associated with a decreased risk of PD. A potential mechanism may be the surgical removal of alpha-synuclein redundancy in these organs. Our data provide additional evidence supporting the importance of the gut-to-brain axis in PD etiology.
Data Availability Statement
The data analyzed in this study were obtained from the Swedish National Board of Health and Welfare and Statistics Sweden and because of Swedish privacy laws we cannot make the data publicly available. Requests to access these datasets should be directed to the Swedish National Board of Health and Welfare and Statistics Sweden after obtaining an ethical approval from a regional ethics review board.
Ethics Statement
The studies involving human participants were reviewed and approved by the Regional Ethics Review Board, Stockholm, Sweden. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Author Contributions
KW and FF were responsible for study concept, study design and funding. BL performed data management and statistical analysis as well as drafted the manuscript. All authors contributed to interpretation of results and critical revision of the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Footnotes
Funding. The study was supported by the Swedish Research Council (Grant no. 2017-02175), the Parkinson Research Foundation in Sweden, and the Swedish Parkinson Foundation. FF was supported by the Senior Researcher Award and Strategic Research Area in Epidemiology at Karolinska Institutet.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2020.00510/full#supplementary-material
References
- 1.Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. (2003) 110:517–36. 10.1007/s00702-002-0808-2 [DOI] [PubMed] [Google Scholar]
- 2.Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci. (2009) 1170:615–22. 10.1111/j.1749-6632.2009.04365.x [DOI] [PubMed] [Google Scholar]
- 3.Klingelhoefer L, Reichmann H. Pathogenesis of parkinson disease–the gut-brain axis and environmental factors. Nat Rev Neurol. (2015) 11:625–36. 10.1038/nrneurol.2015.197 [DOI] [PubMed] [Google Scholar]
- 4.Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. (2015) 14:625–39. 10.1016/S1474-4422(15)00007-1 [DOI] [PubMed] [Google Scholar]
- 5.Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. (2009) 8:382–97. 10.1016/S1474-4422(09)70062-6 [DOI] [PubMed] [Google Scholar]
- 6.Mabbott NA. Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain. Prion. (2012) 6:322–33. 10.4161/pri.20676 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lunny C, Knopp-Sihota JA, Fraser SN. Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies. BMC Neurol. (2013) 13:41. 10.1186/1471-2377-13-41 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sun W, Han X, Wu S, Yang C. Tonsillectomy and the risk of inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. (2016) 31:1085–94. 10.1111/jgh.13273 [DOI] [PubMed] [Google Scholar]
- 9.Mendes A, Goncalves A, Vila-Cha N, Moreira I, Fernandes J, Damasio J, et al. Appendectomy may delay parkinson's disease onset. Mov Disord. (2015) 30:1404–7. 10.1002/mds.26311 [DOI] [PubMed] [Google Scholar]
- 10.Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, et al. The vermiform appendix impacts the risk of developing parkinson's disease. Sci Transl Med. (2018) 10:eaar5280. 10.1126/scitranslmed.aar5280 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marras C, Lang AE, Austin PC, Lau C, Urbach DR. Appendectomy in mid and later life and risk of parkinson's disease: a population-based study. Mov Disord. (2016) 31:1243–7. 10.1002/mds.26670 [DOI] [PubMed] [Google Scholar]
- 12.Svensson E, Horvath-Puho E, Stokholm MG, Sorensen HT, Henderson VW, Borghammer P. Appendectomy and risk of parkinson's disease: a nationwide cohort study with more than 10 years of follow-up. Mov Disord. (2016) 31:1918–22. 10.1002/mds.26761 [DOI] [PubMed] [Google Scholar]
- 13.Yilmaz R, Bayram E, Ulukan C, Altinok MK, Akbostanci MC. Appendectomy history is not related to parkinson's disease. J Parkinsons Dis. (2017) 7:347–52. 10.3233/JPD-171071 [DOI] [PubMed] [Google Scholar]
- 14.Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A. Appendectomy and risk of parkinson's disease in two large prospective cohorts of men and women. Mov Disord. (2018) 33:1492–6. 10.1002/mds.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Svensson E, Henderson VW, Szepligeti S, Stokholm MG, Klug TE, Sorensen HT, et al. Tonsillectomy and risk of parkinson's disease: a danish nationwide population-based cohort study. Mov Disord. (2018) 33:321–4. 10.1002/mds.27253 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Statistics Sweden Täckningsgrad för Den Somatiska Och Psykiatriska Slutenvården. (2016) Available Online at: http://www.scb.se/sv_/Hitta-statistik/Regional-statistik-och-kartor/Regionala-indelningar/Lan-och-kommuner/Lan-och-kommuner-i-kodnummerordning/ (accessed April 9, 2016).
- 17.Swedish National Board of Health Welfare The National Patient Register (2019) Available: http://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/the-national-patient-register/ (accessed Feb 28, 2020).
- 18.Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. (2011) 11:450. 10.1186/1471-2458-11-450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Statistics Sweden SCB-Data för Forskning 2012/Microdata at Statistic Sweden for Research Purposes 2012. (2012) Available Online at: http://www.scb.se/statistik/_publikationer/OV9999_2012A01_BR_X104BR1201.pdf (accessed May 9, 2015).
- 20.Statistics Sweden Folk- och bostadsräkningen 1965–1990. (2019) Available Online at: https://www.scb.se/contentassets/c0dbe46b69f64b90b221bfaaff678d45/be0205_bs_2000.pdf (accessed May 9, 2015).
- 21.Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, et al. Accuracy and sensitivity of parkinsonian disorder diagnoses in two Swedish national health registers. Neuroepidemiology. (2012) 38:186–93. 10.1159/000336356 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of parkinson's disease. Ann Neurol. (2002) 52:276–84. 10.1002/ana.10277 [DOI] [PubMed] [Google Scholar]
- 23.Oldmeadow C, Wood I, Mengersen K, Visscher PM, Martin NG, Duffy DL. Investigation of the relationship between smoking and appendicitis in Australian twins. Ann Epidemiol. (2008) 18:631–6. 10.1016/j.annepidem.2008.04.004 [DOI] [PubMed] [Google Scholar]
- 24.Cinamon U, Goldfarb A, Marom T. The impact of tobacco smoking upon chronic/recurrent tonsillitis and post tonsillectomy bleeding. Int Arch Otorhinolaryngol. (2017) 21:165–70. 10.1055/s-0036-1593835 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and parkinson disease: a Swedish register-based matched-cohort study. Neurology. (2017) 88:1996–2002. 10.1212/WNL.0000000000003961 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. (1987) 40:373–83. 10.1016/0021-9681(87)90171-8 [DOI] [PubMed] [Google Scholar]
- 27.Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P. Pathological α-synuclein in gastrointestinal tissues from prodromal parkinson disease patients. Ann Neurol. (2016) 79:940–9. 10.1002/ana.24648 [DOI] [PubMed] [Google Scholar]
- 28.Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord. (2014) 29:991–8. 10.1002/mds.25779 [DOI] [PubMed] [Google Scholar]
- 29.Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of parkinson's disease. Ann Neurol. (2015) 78:522–9. 10.1002/ana.24448 [DOI] [PubMed] [Google Scholar]
- 30.Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in parkinson's disease. Nat Med. (2008) 14:504–6. 10.1038/nm1747 [DOI] [PubMed] [Google Scholar]
- 31.Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with parkinson's disease suggest host-to-graft disease propagation. Nat Med. (2008) 14:501–3. 10.1038/nm1746 [DOI] [PubMed] [Google Scholar]
- 32.Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, et al. Progression of parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE. (2010) 5:e8762. 10.1371/journal.pone.0008762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hawkes CH, Del Tredici K, Braak H. A timeline for parkinson's disease. Parkinsonism Relat Disord. (2010) 16:79–84. 10.1016/j.parkreldis.2009.08.007 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data analyzed in this study were obtained from the Swedish National Board of Health and Welfare and Statistics Sweden and because of Swedish privacy laws we cannot make the data publicly available. Requests to access these datasets should be directed to the Swedish National Board of Health and Welfare and Statistics Sweden after obtaining an ethical approval from a regional ethics review board.